Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-25-101586
Filing Date
2025-10-22
Accepted
2025-10-22 17:26:39
Documents
5

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm2529228d7_defa14a.htm DEFA14A 157602
2 GRAPHIC image_001.jpg GRAPHIC 2237
3 GRAPHIC image_002.jpg GRAPHIC 663
4 GRAPHIC image_003.jpg GRAPHIC 2478
5 GRAPHIC image_005.jpg GRAPHIC 2457
  Complete submission text file 0001104659-25-101586.txt   170092
Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address 10 EARLSFORT TERRACE DUBLIN 2 Ireland D02 T380 636-449-1830
AVADEL PHARMACEUTICALS PLC (Filer) CIK: 0001012477 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37977 | Film No.: 251410895
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)